A randomized controlled trial comparing a telemedicine therapeutic intervention with routine care in adults with type 1 diabetes mellitus treated by insulin pumps
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Aim To examine the effectiveness and safety over a 12-month period of a telemedicine intervention in adults with type 1 diabetes (T1D) treated with insulin pumps. Methods 74 T1D patients on insulin pumps for at least 1 year (mean 19.5 [11.5] years) and HbA1 c ≥ 6.5% (≥ 48 mmol/mol) were randomized to the telemedicine (n = 37) or the standard care group (n = 37). The intervention group was instructed to download data from insulin pumps and glucometers monthly. They received immediate phone feedback and recommendations for insulin dose adjustment; and face-to-face visits once in 6 months, compared to once every 3 months for the standard care group. Satisfaction with treatment, quality of life and frequency of hypoglycemic events was evaluated. Results The mean changes in HbA1c adjusted to baseline were - 0.08% (0.25 mmol/mol) vs. - 0.01% (0.03 mmol/mol), in the intervention and control groups, respectively (p = 0.18) at 12 months, without an increased frequency of hypoglycemia. Patients in the intervention group felt satisfied and interested in continuing with the treatment (p = 0.04). The quality of life scores were similar in both groups. Direct total costs were 24% less in the intervention group, and indirect total costs decreased by 22% compared to the year preceding the study. Conclusions Internet-based insulin dose adjustment is as effective and safe as routine care in adults with type 1 diabetes treated by insulin pumps. For suitable patients, some of the time-consuming…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Those persons with lower socioeconomic status have a higher risk for developing T2D, worse DM control, and more DM-related complications.1661–1663”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1661]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Internet-based cognitive behaviour therapy for symptoms of depression and anxiety: A meta-analysis
SPEK, V., CUIJPERS, P., NYKLÍČEK, I., RIPER, H., KEYZER, J., & POP, V. (2007) · Psychological Medicine · doi:10.1017/s0033291706008944 · Cited by 1,586
Hex, N., Bartlett, C., Wright, D., Taylor, M., & Varley, D. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03698.x · Cited by 819
Clark, R. A., Inglis, S. C., McAlister, F. A., Cleland, J. G. F., & Stewart, S. (2007) · BMJ · doi:10.1136/bmj.39156.536968.55 · Cited by 672
Bradley, C., Todd, C., Gorton, T., Symonds, E., Martin, A., & Plowright, R. (1999) · Quality of Life Research · doi:10.1023/a:1026485130100 · Cited by 668
Handbook of Psychology and Diabetes
(2013) · Routledge eBooks · doi:10.4324/9781315077369 · Cited by 661
Patient perceptions of diabetes and diabetes therapy: assessing quality of life
Bradley, C., & Speight, J. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.279 · Cited by 362
(1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540170053032 · Cited by 349
Charpentier, G., Benhamou, P.-Y., Dardari, D., Clergeot, A., Franc, S., Schaepelynck-Belicar, P., Catargi, B., Melki, V., Chaillous, L., Farret, A., et al. (2011) · Diabetes Care · doi:10.2337/dc10-1259 · Cited by 292
The Diabetes Control and Complications Trial Research Group (1996) · Diabetes Care · doi:10.2337/diacare.19.3.195 · Cited by 245
Home telehealth for diabetes management: a systematic review and meta‐analysis
Polisena, J., Tran, K., Cimon, K., Hutton, B., McGill, S., & Palmer, K. (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01057.x · Cited by 239
Farmer, A., Gibson, O. J., Tarassenko, L., & Neil, A. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01627.x · Cited by 211
Rossi, M. C. E., Nicolucci, A., Di Bartolo, P., Bruttomesso, D., Girelli, A., Ampudia, F. J., Kerr, D., Ceriello, A., Mayor, C. D. L. Q., Pellegrini, F., et al. (2010) · Diabetes Care · doi:10.2337/dc09-1327 · Cited by 174
Telecare for Patients With Type 1 Diabetes and Inadequate Glycemic Control
Montori, V. M., Helgemoe, P. K., Guyatt, G. H., Dean, D. S., Leung, T. W., Smith, S. A., & Kudva, Y. C. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1088 · Cited by 169
Jackson, C. L., Bolen, S., Brancati, F. L., Batts-Turner, M. L., & Gary, T. L. (2006) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2005.00310.x · Cited by 168
Farmer, A. J., Gibson, O. J., Dudley, C., Bryden, K., Hayton, P. M., Tarassenko, L., & Neil, A. (2005) · Diabetes Care · doi:10.2337/diacare.28.11.2697 · Cited by 153
Modem Transmission of Glucose Values Reduces the Costs and Need for Clinic Visits
Chase, H. P., Pearson, J. A., Wightman, C., Roberts, M. D., Oderberg, A. D., & Garg, S. K. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1475 · Cited by 131
Herman, W. H., Petersen, M., & Kalyani, R. R. (2017) · Diabetes Care · doi:10.2337/dci17-0007 · Cited by 124
Lee, S. W. H., Ooi, L., & Lai, Y. K. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00330 · Cited by 117
Teleconsultation in type 1 diabetes mellitus (TELEDIABE)
Bertuzzi, F., Stefani, I., Rivolta, B., Pintaudi, B., Meneghini, E., Luzi, L., & Mazzone, A. (2018) · Acta Diabetologica · doi:10.1007/s00592-017-1084-9 · Cited by 58
Telecare of diabetic patients with intensified insulin therapy. A randomized clinical trial.
Biermann, E., Dietrich, W., & Standl, E. (2000) · PubMed · Cited by 38
[Description of a diabetes disease register extracted from a central database].
Heymann, A. D., Chodick, G., Halkin, H., Kokia, E. S., & Shalev, V. (2007) · PubMed · Cited by 17
Research works printed but not linked: 1
- Cahn A, Raz I (2017) Clinical guide for the diabetes treatment. The National Council of Diabetes, Israel. The Medical Group, Tel Aviv
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Grunberger, G., Sherr, J., Allende, M., Blevins, T., Bode, B., Handelsman, Y., Hellman, R., Lajara, R., Roberts, V. L., Rodbard, D., et al. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.04.008 · Cited by 288
Mao, Y., Lin, W., Wen, J., & Chen, G. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001225 · Cited by 108
Konnyu, K. J., Yogasingam, S., Lépine, J., Sullivan, K., Alabousi, M., Edwards, A., Hillmer, M., Karunananthan, S., Lavis, J. N., Linklater, S., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014513 · Cited by 37
Udsen, F. W., Hangaard, S., Bender, C., Andersen, J. S., Kronborg, T., Vestergaard, P., Hejlesen, O. K., & Laursen, S. H. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221076874 · Cited by 43
Metadata
- Authors
- Yaron, M., Sher, B., Sorek, D., Shomer, M., Levek, N., Schiller, T., Gaspar, M., Frumkin Ben-David, R., Mazor-Aronovitch, K., Tish, E., Shapira, Y., & Pinhas-Hamiel, O.
- Affiliations
- Tel Aviv University (IL)
- Corresponding author
- Yaron, Marianna
- ORCID
- Yaron, Marianna
- Venue
- Acta Diabetologica
- Published
- 2019-02-19
- Volume
- 56
- Issue
- 6
- Pages
- 667-673
- ISSN
- 0940-5429 (ISSN-L)
- 1432-5233
- OpenAlex
- W2917806945
- Cited by
- 29
- References
- 22
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 2 · 2022: 7 · 2021: 10 · 2020: 4 · 2019: 1
- FWCI
- 4.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Acta Diabetologica (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Maccabbi Healthcare Services
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- type 1 diabetes, insulin pump, telemedicine, glycemic control, HbA1c, hypoglycemia, quality of life, treatment satisfaction, cost-effectiveness, digital health interventions
- MeSH terms
- Adult, Aged, Diabetes Mellitus, Type 1, Female, Humans, Hypoglycemic Agents, Insulin, Insulin Infusion Systems, Male, Middle Aged, Blood Glucose Self-Monitoring, Telemedicine, Internet
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.